Cargando…
480. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant among Immunocompromised Patients
BACKGROUND: Immunocompromised patients with coronavirus disease (COVID-19) shed SARS-CoV-2 RNA longer than usual, but the duration of viral shedding and criteria for nosocomial de-isolation in these patients remains unclear. METHODS: A prospective cohort study was performed at two tertiary medical c...
Autores principales: | KAMEGAI, K O H E I, Iwamoto, Noriko, Itoh, Naoya, Ishikane, Masahiro, Asai, Yusuke, Akazawa, Nana, Fuwa, Noriko, Takasaki, Jin, Hojo, Masayuki, Hangaishi, Akira, Togano, Tomiteru, Teruya, Katsuji, Kanno, Takayuki, Takahashi, Kenichiro, Miyamoto, Sho, Hirata, Yuichiro, Saito, Tomoya, Katano, Harutaka, Suzuki, Tadaki, Ohmagari, Norio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677867/ http://dx.doi.org/10.1093/ofid/ofad500.550 |
Ejemplares similares
-
A Fatal Breakthrough COVID-19 Case Following Bendamustine-Rituximab Therapy
por: Kamegai, Kohei, et al.
Publicado: (2022) -
1071. Retrospective study evaluating the cytokine dynamics in COVID-19 patients who were treated with casirivimab/imdevimab
por: Sugita, Akiho, et al.
Publicado: (2022) -
The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan
por: Togano, Tomiteru, et al.
Publicado: (2021) -
Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees
por: Takahashi, Kenichiro, et al.
Publicado: (2022) -
Efficacy and Safety of Treatment with Plasma from COVID-19-Recovered Individuals
por: Terada, Mari, et al.
Publicado: (2023)